Alan I. Reed
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Alan I. Reed has a total of 356 co-authors. Here are the top co-authors by number of shared publications:
- Stuart J. Knechtle
Duke Transplant Center, Department of Surgery, Duke University Medical Center, Durham, NC 27710
26 shared publications Richard J. Howard
Division of Transplantation and Hepatobiliary Surgery, Department of Surgery, University of Florida College of Medicine, Gainesville, FL
22 shared publicationsAlan W. Hemming
Division of Transplantation and Hepatobiliary Surgery, Department of Surgery, University of Florida College of Medicine, Gainesville, FL
18 shared publicationsF O Belzer
16 shared publicationsJ D Pirsch
Department of Medicine, University of Wisconsin School of Medicine, Madison 53792
16 shared publicationsM Kalayoglu
16 shared publications
Latest Publications
- Open Access
- 23 June 2026
- Published by Wiley in Clinical Transplantation
- Vol. 40 (6) , e70604
Impact of the 2024 Organ Procurement and Transplantation Network Kidney Donor Profile Index Rescoring on Donor Kidney Utilization and Allocation out of Sequence: A one‐Year Analysis
Background: In October 2024, the Organ Procurement and Transplantation Network (OPTN) removed hepatitis C virus (HCV) positivity and African American/Black (AA/B) donor race from the Kidney Donor Profile Index (KDPI) calculation. This study evaluates the early impact of this policy change on kidney utilization during its first year. Methods: We performed a retrospective analysis of OPTN data for organ procurements and adult deceased‐donor kidney transplants between November 2023 and October 2025. Donors were stratified by HCV status and race. Kidney utilization and allocation out‐of‐sequence (AOOS) were compared between pre‐policy (November 2023–October 2024) and post‐policy (November 2024–October 2025) periods. Results: The policy revision was associated with redistribution of HCV+ and AA/B donor kidneys toward lower KDPI category, with increases of 989% and 144%, respectively, in the 0–20% KDPI range. Overall utilization increased among AA/B (66.9% to 71.5%), non‐AA/B (70.1% to 72.1%), HCV− (69.6% to 72.0%), and HCV+ donors (70.3% to 72.5%). However, utilization within individual KDPI categories declined for AA/B and HCV+ donors across most strata, except for the 21–34% category among HCV+ donors. AOOS decreased from 20.2% to 16.8% (absolute reduction 3.4%; 95% confidence interval, −4.1% to −2.6%). Conclusion: The policy was associated with increased overall utilization across donor groups. However, gains among AA/B and HCV+ donors appear primarily driven by redistribution into different allocation sequences rather than improvement in within‐category utilization. Reduced AOOS suggests improved allocation efficiency, though findings may be influenced by concurrent regulatory changes.
- 23 June 2026
- Published by Wiley in Clinical Transplantation
- Vol. 40 (6) , e70604
Open AccessImpact of the 2024 Organ Procurement and Transplantation Network Kidney Donor Profile Index Rescoring on Donor Kidney Utilization and Allocation out of Sequence: A one‐Year Analysis
Background: In October 2024, the Organ Procurement and Transplantation Network (OPTN) removed hepatitis C virus (HCV) positivity and African American/Black (AA/B) donor race from the Kidney Donor Profile Index (KDPI) calculation. This study evaluates the early impact of this policy change on kidney utilization during its first year. Methods: We performed a retrospective analysis of OPTN data for organ procurements and adult deceased‐donor kidney transplants between November 2023 and October 2025. Donors were stratified by HCV status and race. Kidney utilization and allocation out‐of‐sequence (AOOS) were compared between pre‐policy (November 2023–October 2024) and post‐policy (November 2024–October 2025) periods. Results: The policy revision was associated with redistribution of HCV+ and AA/B donor kidneys toward lower KDPI category, with increases of 989% and 144%, respectively, in the 0–20% KDPI range. Overall utilization increased among AA/B (66.9% to 71.5%), non‐AA/B (70.1% to 72.1%), HCV− (69.6% to 72.0%), and HCV+ donors (70.3% to 72.5%). However, utilization within individual KDPI categories declined for AA/B and HCV+ donors across most strata, except for the 21–34% category among HCV+ donors. AOOS decreased from 20.2% to 16.8% (absolute reduction 3.4%; 95% confidence interval, −4.1% to −2.6%). Conclusion: The policy was associated with increased overall utilization across donor groups. However, gains among AA/B and HCV+ donors appear primarily driven by redistribution into different allocation sequences rather than improvement in within‐category utilization. Reduced AOOS suggests improved allocation efficiency, though findings may be influenced by concurrent regulatory changes.
- Open Access
- 27 June 2025
- Published by Wolters Kluwer Health in Transplantation Direct
- Vol. 11 (7) , e1827
Outcomes of High Kidney Donor Profile Index Hepatitis C Nucleic Acid Testing Positive Kidneys are Equivalent to Matched Hepatitis C Nucleic Acid Testing Negative Kidneys
Background.: A recent Organ Procurement and Transplant Network policy change removes hepatitis C virus (HCV) status and race from the Kidney Donor Profile Index (KDPI) calculation, thereby lowering the KDPI of HCV nucleic acid testing positive (NAT+) kidneys and increasing their allocation priority. However, even in the era of direct-acting antivirals, high KDPI HCV NAT+ kidneys exhibited higher discard rates compared with their HCV NAT– counterparts, and outcome data for this “high-risk” group remain limited. This study aims to address this knowledge gap by providing comprehensive outcome data to better inform organ allocation and selection decisions under the new KDPI framework. Methods.: Using national transplant data from 2015 to 2023, we analyzed adult deceased donor kidney transplants stratified by KDPI and HCV NAT status. An exact matching model was used to identify the matched HCV NAT– group. Results.: No significant differences were observed in delayed graft function, rejection, or patient and graft survival between high KDPI HCV NAT+ and matched HCV NAT– recipients. High KDPI HCV NAT+ kidneys were more often allocated regionally or nationally, with 67.6% occurring in 4 regions. Their recipients were more likely to have a high school education and shorter wait times. After the policy change, >90% of prior high KDPI HCV NAT+ kidneys will no longer be classified as high KDPI. Conclusions.: Our findings support the safe utilization of previously high KDPI HCV NAT+ kidneys after a policy change. Although the revised KDPI may assist clinicians in identifying higher-quality organs, its impact on existing sociodemographic disparities and overall organ utilization rate remains uncertain.
- 27 June 2025
- Published by Wolters Kluwer Health in Transplantation Direct
- Vol. 11 (7) , e1827
Open AccessOutcomes of High Kidney Donor Profile Index Hepatitis C Nucleic Acid Testing Positive Kidneys are Equivalent to Matched Hepatitis C Nucleic Acid Testing Negative Kidneys
Background.: A recent Organ Procurement and Transplant Network policy change removes hepatitis C virus (HCV) status and race from the Kidney Donor Profile Index (KDPI) calculation, thereby lowering the KDPI of HCV nucleic acid testing positive (NAT+) kidneys and increasing their allocation priority. However, even in the era of direct-acting antivirals, high KDPI HCV NAT+ kidneys exhibited higher discard rates compared with their HCV NAT– counterparts, and outcome data for this “high-risk” group remain limited. This study aims to address this knowledge gap by providing comprehensive outcome data to better inform organ allocation and selection decisions under the new KDPI framework. Methods.: Using national transplant data from 2015 to 2023, we analyzed adult deceased donor kidney transplants stratified by KDPI and HCV NAT status. An exact matching model was used to identify the matched HCV NAT– group. Results.: No significant differences were observed in delayed graft function, rejection, or patient and graft survival between high KDPI HCV NAT+ and matched HCV NAT– recipients. High KDPI HCV NAT+ kidneys were more often allocated regionally or nationally, with 67.6% occurring in 4 regions. Their recipients were more likely to have a high school education and shorter wait times. After the policy change, >90% of prior high KDPI HCV NAT+ kidneys will no longer be classified as high KDPI. Conclusions.: Our findings support the safe utilization of previously high KDPI HCV NAT+ kidneys after a policy change. Although the revised KDPI may assist clinicians in identifying higher-quality organs, its impact on existing sociodemographic disparities and overall organ utilization rate remains uncertain.
- Open Access
- 7 April 2022
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 41 (4) , S285
Extracorporeal Photopheresis in Lung Transplantation - New Frontiers in Infection Immunomodulation - A Case Series
- 7 April 2022
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 41 (4) , S285
Open AccessExtracorporeal Photopheresis in Lung Transplantation - New Frontiers in Infection Immunomodulation - A Case Series
- Open Access
- 1 March 2021
- Published by Taylor & Francis in Advances in Medical Education and Practice
- Vol. ume 12, 305-306
A Response to Viewpoints on Healthcare Delivery Science Education Among Practicing Physicians in a Rural State [Response to Letter]
A Response to Viewpoints on Healthcare Delivery Science Education Among Practicing Physicians in a Rural State [Response to Letter]
- 1 March 2021
- Published by Taylor & Francis in Advances in Medical Education and Practice
- Vol. ume 12, 305-306
Open AccessA Response to Viewpoints on Healthcare Delivery Science Education Among Practicing Physicians in a Rural State [Response to Letter]
A Response to Viewpoints on Healthcare Delivery Science Education Among Practicing Physicians in a Rural State [Response to Letter]
- Open Access
- 1 January 2021
- Published by Taylor & Francis in Advances in Medical Education and Practice
- Vol. ume 12, 29-39
Viewpoints on Healthcare Delivery Science Education Among Practicing Physicians in a Rural State
Introduction: Healthcare Delivery Science Education (HDSE) covers important aspects of the business of medicine, including, operations management, managerial accounting, entrepreneurship, finance, marketing, negotiations, e-health and policy/advocacy. We need to investigate and understand practicing physicians’ viewpoints on HDSE in order to inform interventions capable of preventing the double loss phenomena and improving medical and continuing medical education opportunities in HDSE. This qualitative study aims to provide a rich, contextualized understanding of the HDSE experiences and interests of physicians practicing in a rural state through the intensive study of particular cases. Materials and Methods: We interviewed 18 practicing physicians from a rural, Midwestern state over the telephone about their viewpoints on past experiences obtaining HDSE, interest in HDSE, barriers to pursuing HDSE, and interest in an example HDSE certificate program. Results: Salient themes in our study were that physicians were interested in HDSE and believed HDSE could lead to improved patient care and practice efficiency. However, many of the respondents had not received longitudinal, diversified, didactic or practical HDSE. Time limited many physicians from pursuing HDSE opportunities. Many physicians in the study were interested in the example HDSE certificate program. Discussion and Conclusions: Physicians in our qualitative study were interested in obtaining HDSE and had not received diversified, didactic HDSE in the past. Our research suggests innovative HDSE programs will likely be utilized and pursued if they are developed.
- 1 January 2021
- Published by Taylor & Francis in Advances in Medical Education and Practice
- Vol. ume 12, 29-39
Open AccessViewpoints on Healthcare Delivery Science Education Among Practicing Physicians in a Rural State
Introduction: Healthcare Delivery Science Education (HDSE) covers important aspects of the business of medicine, including, operations management, managerial accounting, entrepreneurship, finance, marketing, negotiations, e-health and policy/advocacy. We need to investigate and understand practicing physicians’ viewpoints on HDSE in order to inform interventions capable of preventing the double loss phenomena and improving medical and continuing medical education opportunities in HDSE. This qualitative study aims to provide a rich, contextualized understanding of the HDSE experiences and interests of physicians practicing in a rural state through the intensive study of particular cases. Materials and Methods: We interviewed 18 practicing physicians from a rural, Midwestern state over the telephone about their viewpoints on past experiences obtaining HDSE, interest in HDSE, barriers to pursuing HDSE, and interest in an example HDSE certificate program. Results: Salient themes in our study were that physicians were interested in HDSE and believed HDSE could lead to improved patient care and practice efficiency. However, many of the respondents had not received longitudinal, diversified, didactic or practical HDSE. Time limited many physicians from pursuing HDSE opportunities. Many physicians in the study were interested in the example HDSE certificate program. Discussion and Conclusions: Physicians in our qualitative study were interested in obtaining HDSE and had not received diversified, didactic HDSE in the past. Our research suggests innovative HDSE programs will likely be utilized and pursued if they are developed.
- Open Access
- 1 October 2020
- Published by Taylor & Francis in Journal of Healthcare Leadership
- Vol. ume 12, 95-102
An Unmet Need in Healthcare Leadership: A Survey of Practicing Physicians’ Perspectives on Healthcare Delivery Science Education
Background: Healthcare delivery science education (HDSE) is increasingly needed by physicians balancing clinical care, practice management, and leadership responsibilities in their daily lives. However, most practicing physicians have received little HDSE in undergraduate through residency training. The purpose of this study is to 1) quantify the perception of the need for HDSE and interest in HDSE among a diverse sample of physicians, and 2) determine if perspectives on HDSE vary by specialty, rurality, and years in practice. Methods: Using a cross-sectional, single state, mailed questionnaire, we surveyed 170 physicians about their perspectives on HDSE and interest in an HDSE program. Descriptive statistics and a multivariable logistic regression are presented. Results: Among the 70.5% of responding eligible physicians, 75% of physicians had less HDSE than they would like and 90% were interested in obtaining more HDSE. Thirty-five percent of physicians were interested in joining the described HDSE program. The most prevalent barriers to obtaining HDSE were a lack of time and existing programs. Physician perspectives were similar across specialties, years in practice, and rurality. Conclusion: There is a high unmet need for HDSE among physicians. Diverse and innovative HDSE programming needs to be developed to meet this need. Programming should be developed not only for physicians but also for undergraduate through residency training programs.
- 1 October 2020
- Published by Taylor & Francis in Journal of Healthcare Leadership
- Vol. ume 12, 95-102
Open AccessAn Unmet Need in Healthcare Leadership: A Survey of Practicing Physicians’ Perspectives on Healthcare Delivery Science Education
Background: Healthcare delivery science education (HDSE) is increasingly needed by physicians balancing clinical care, practice management, and leadership responsibilities in their daily lives. However, most practicing physicians have received little HDSE in undergraduate through residency training. The purpose of this study is to 1) quantify the perception of the need for HDSE and interest in HDSE among a diverse sample of physicians, and 2) determine if perspectives on HDSE vary by specialty, rurality, and years in practice. Methods: Using a cross-sectional, single state, mailed questionnaire, we surveyed 170 physicians about their perspectives on HDSE and interest in an HDSE program. Descriptive statistics and a multivariable logistic regression are presented. Results: Among the 70.5% of responding eligible physicians, 75% of physicians had less HDSE than they would like and 90% were interested in obtaining more HDSE. Thirty-five percent of physicians were interested in joining the described HDSE program. The most prevalent barriers to obtaining HDSE were a lack of time and existing programs. Physician perspectives were similar across specialties, years in practice, and rurality. Conclusion: There is a high unmet need for HDSE among physicians. Diverse and innovative HDSE programming needs to be developed to meet this need. Programming should be developed not only for physicians but also for undergraduate through residency training programs.
- 18 August 2020
- Published by Wiley in Clinical Transplantation
- Vol. 35 (1) , e14068
A simple risk‐based reimbursement system for kidney transplant
Transplant centers were challenged by the Executive Order on Advancing Kidney health to increase access to kidney transplant (KTx) by accepting higher risk patients and organs. However, Medicare reimbursement for KTx does not include adjustment for major complicating comorbidities (MCCs) like other transplants. The prevalence of MCCs was assessed for KTx performed from 10/15 to 10/19 at a single academic center, using Medicare ICD10 MCC criteria exclusive of end‐stage kidney disease. KTx hospital resource utilization and estimated margin, assuming Medicare reimbursement, were determined for cases with and without MCC. Among 260 KTx recipients, 49 (19%) had an MCC. Patients with MCCs had longer wait times (1121 days vs 703 days, P < .001); however, there were no differences in age, gender, race, or diagnosis. Donor characteristics associated with an MCC included greater cold ischemic time (1042 vs 670 minutes, P < .001) and fewer living donor KTx (9% vs 32%, P < .001). KTx cost, exclusive of organ acquisition, was 31% higher (MCC: $38 293 vs No MCC: $29 132) and estimated margin was markedly lower (‐$7750 vs ‐$1001, P = .001). In conclusion, KTx with qualifying MCCs resulted in significant financial losses and modification of KTx payment methodology to align with other organ transplants is needed.
- 18 August 2020
- Published by Wiley in Clinical Transplantation
- Vol. 35 (1) , e14068
A simple risk‐based reimbursement system for kidney transplant
Transplant centers were challenged by the Executive Order on Advancing Kidney health to increase access to kidney transplant (KTx) by accepting higher risk patients and organs. However, Medicare reimbursement for KTx does not include adjustment for major complicating comorbidities (MCCs) like other transplants. The prevalence of MCCs was assessed for KTx performed from 10/15 to 10/19 at a single academic center, using Medicare ICD10 MCC criteria exclusive of end‐stage kidney disease. KTx hospital resource utilization and estimated margin, assuming Medicare reimbursement, were determined for cases with and without MCC. Among 260 KTx recipients, 49 (19%) had an MCC. Patients with MCCs had longer wait times (1121 days vs 703 days, P < .001); however, there were no differences in age, gender, race, or diagnosis. Donor characteristics associated with an MCC included greater cold ischemic time (1042 vs 670 minutes, P < .001) and fewer living donor KTx (9% vs 32%, P < .001). KTx cost, exclusive of organ acquisition, was 31% higher (MCC: $38 293 vs No MCC: $29 132) and estimated margin was markedly lower (‐$7750 vs ‐$1001, P = .001). In conclusion, KTx with qualifying MCCs resulted in significant financial losses and modification of KTx payment methodology to align with other organ transplants is needed.
- Open Access
- 27 September 2019
- Published by Elsevier in American Journal of Transplantation
- Vol. 20 (5) , 1244-1250
Implications of the Advancing American Kidney Health Initiative for kidney transplant centers
- 27 September 2019
- Published by Elsevier in American Journal of Transplantation
- Vol. 20 (5) , 1244-1250
Open AccessImplications of the Advancing American Kidney Health Initiative for kidney transplant centers
- Open Access
- 23 May 2018
- Published by Elsevier in American Journal of Transplantation
- Vol. 18 (8) , 1865-1874
Implementing an innovated preservation technology: The American Society of Transplant Surgeons’ (ASTS) Standards Committee White Paper on Ex Situ Liver Machine Perfusion
- 23 May 2018
- Published by Elsevier in American Journal of Transplantation
- Vol. 18 (8) , 1865-1874
Open AccessImplementing an innovated preservation technology: The American Society of Transplant Surgeons’ (ASTS) Standards Committee White Paper on Ex Situ Liver Machine Perfusion
- Open Access
- 20 April 2018
- Published by Elsevier in American Journal of Transplantation
- Vol. 18 (8) , 2094-2095
Transplantation in value-based care for patients with renal failure
- 20 April 2018
- Published by Elsevier in American Journal of Transplantation
- Vol. 18 (8) , 2094-2095
Open AccessTransplantation in value-based care for patients with renal failure